SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-000755
Filing Date
2024-01-08
Accepted
2024-01-08 06:30:32
Documents
44
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gthx-20240108.htm   iXBRL 8-K 29114
2 EX-99.1 confidential-g1therapeut.htm EX-99.1 33371
6 confidential-g1therapeut001.jpg GRAPHIC 89810
7 confidential-g1therapeut002.jpg GRAPHIC 225602
8 confidential-g1therapeut003.jpg GRAPHIC 140645
9 confidential-g1therapeut004.jpg GRAPHIC 48713
10 confidential-g1therapeut005.jpg GRAPHIC 81433
11 confidential-g1therapeut006.jpg GRAPHIC 93036
12 confidential-g1therapeut007.jpg GRAPHIC 105843
13 confidential-g1therapeut008.jpg GRAPHIC 102615
14 confidential-g1therapeut009.jpg GRAPHIC 123557
15 confidential-g1therapeut010.jpg GRAPHIC 47006
16 confidential-g1therapeut011.jpg GRAPHIC 121011
17 confidential-g1therapeut012.jpg GRAPHIC 115342
18 confidential-g1therapeut013.jpg GRAPHIC 100195
19 confidential-g1therapeut014.jpg GRAPHIC 88838
20 confidential-g1therapeut015.jpg GRAPHIC 106785
21 confidential-g1therapeut016.jpg GRAPHIC 124808
22 confidential-g1therapeut017.jpg GRAPHIC 114088
23 confidential-g1therapeut018.jpg GRAPHIC 49633
24 confidential-g1therapeut019.jpg GRAPHIC 122740
25 confidential-g1therapeut020.jpg GRAPHIC 86936
26 confidential-g1therapeut021.jpg GRAPHIC 93264
27 confidential-g1therapeut022.jpg GRAPHIC 112356
28 confidential-g1therapeut023.jpg GRAPHIC 85303
29 confidential-g1therapeut024.jpg GRAPHIC 48546
30 confidential-g1therapeut025.jpg GRAPHIC 117907
31 confidential-g1therapeut026.jpg GRAPHIC 103787
32 confidential-g1therapeut027.jpg GRAPHIC 131770
33 confidential-g1therapeut028.jpg GRAPHIC 65599
34 confidential-g1therapeut029.jpg GRAPHIC 72943
35 confidential-g1therapeut030.jpg GRAPHIC 122835
36 confidential-g1therapeut031.jpg GRAPHIC 81747
  Complete submission text file 0001628280-24-000755.txt   4511305

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20240108.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20240108_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20240108_pre.xml EX-101.PRE 13060
38 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20240108_htm.xml XML 2833
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 24518224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)